Drawing for SIMPLESTEP IGNITE

USPTO serial 99564094

SIMPLESTEP IGNITE

Reviewed by CopyMark Law Group

Status 641Office Action
Filing date
Status date
Registration date
—
Examiner
JOHNSON, AISHA CLARKE
Law office
TMEG LAW OFFICE 101

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 641: Status 641 means the USPTO mailed a non-final Office Action identifying issues with your application. You typically have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

Need help with SIMPLESTEP IGNITE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher M. Kindel

Christopher M. Kindel Pirkey Barber PLLC1801 East 6th Street, Suite 300Austin, TX 78702United States

Goods and services

ClassDescriptionStatusFirst use
001Assay kits consisting of chemical reagents and antibodies for in vitro scientific and research use; in vitro immunoassay kits for research laboratory use; chemiluminescent reagents and substrates for laboratory use; chemiluminescence detection assays for scientific research and research laboratory use; enzyme substrates for chemiluminescence assays for scientific research purposes; antibodies, peptides, enzymes, complementary deoxyribonucleic acid kits, lysates and vectors, lipids, reagents, stem cells, loading controls in the nature of loading control antibodies and proteins, tags and markers, namely, tag and marker antibodies and proteins for scientific research and research laboratory use; cell line arrays, cell line arrays and tissue arrays, all for medical and scientific research purposesACTIVE—
009Luminometers and chemiluminescence readers for scientific and laboratory use; downloadable electronic publications in the nature of books, magazines, manuals, guides and technical protocol guides in the field of research, development, technological and user information for use in enhancing assay kits consisting of chemical and chemiluminescent reagents and antibodies, chemiluminescence detection assays, in vitro immunoassay kits for research laboratory use, antibodies, peptides, enzymes, complementary deoxyribonucleic acid kits, lysates and vectors, lipids, reagents, stem cells, loading controls in the nature of loading control antibodies and proteins, tags and markers, namely, tag and marker antibodies and proteins, cell line arrays, cell line arrays and tissue arrays, all for medical and scientific research purposesACTIVE—
042Providing scientific information relating to assay kits consisting of chemical and chemiluminescent reagents and antibodies, chemiluminescence detection assays, in vitro immunoassay kits for research laboratory use, antibodies, peptides, enzymes, complementary deoxyribonucleic acid kits, lysates and vectors, lipids, reagents, stem cells, loading controls in the nature of loading control antibodies and proteins, tags and markers, namely, tag and marker antibodies and proteins, cell line arrays, cell line arrays and tissue arrays, all for medical and scientific research purposes; providing scientific and medical research information on immune response and protocols relating to antibody use; providing scientific information on the selection, production, purification, application, structure and activities of antibodies; providing technical support relating to antibody selection and use, namely, providing technical consultation services; online computer services in the nature of providing a search engine for obtaining data, namely, searching, retrieving, and providing information on antibodies and research topics pertaining to antibodies on a global computer networkACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (GNRN): A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.

DateCodeEventWhat it means
Sep 22, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Aug 25, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 4, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 4, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 4, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Aug 4, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 4, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 29, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 28, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 28, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 15, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 15, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2026DOCKASSIGNED TO EXAMINER—
Apr 16, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 23, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 23, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance